312 related articles for article (PubMed ID: 30642766)
41. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
Tomassini J; Selnick H; Davies ME; Armstrong ME; Baldwin J; Bourgeois M; Hastings J; Hazuda D; Lewis J; McClements W
Antimicrob Agents Chemother; 1994 Dec; 38(12):2827-37. PubMed ID: 7695269
[TBL] [Abstract][Full Text] [Related]
42. Cap-snatching mechanism in yeast L-A double-stranded RNA virus.
Fujimura T; Esteban R
Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17667-71. PubMed ID: 21987792
[TBL] [Abstract][Full Text] [Related]
43. Differential activation of the influenza virus polymerase via template RNA binding.
Cianci C; Tiley L; Krystal M
J Virol; 1995 Jul; 69(7):3995-9. PubMed ID: 7769657
[TBL] [Abstract][Full Text] [Related]
44. Two separate sequences of PB2 subunit constitute the RNA cap-binding site of influenza virus RNA polymerase.
Honda A; Mizumoto K; Ishihama A
Genes Cells; 1999 Aug; 4(8):475-85. PubMed ID: 10526235
[TBL] [Abstract][Full Text] [Related]
45. Hybrid Gene Origination Creates Human-Virus Chimeric Proteins during Infection.
Ho JSY; Angel M; Ma Y; Sloan E; Wang G; Martinez-Romero C; Alenquer M; Roudko V; Chung L; Zheng S; Chang M; Fstkchyan Y; Clohisey S; Dinan AM; Gibbs J; Gifford R; Shen R; Gu Q; Irigoyen N; Campisi L; Huang C; Zhao N; Jones JD; van Knippenberg I; Zhu Z; Moshkina N; Meyer L; Noel J; Peralta Z; Rezelj V; Kaake R; Rosenberg B; Wang B; Wei J; Paessler S; Wise HM; Johnson J; Vannini A; Amorim MJ; Baillie JK; Miraldi ER; Benner C; Brierley I; Digard P; Łuksza M; Firth AE; Krogan N; Greenbaum BD; MacLeod MK; van Bakel H; Garcìa-Sastre A; Yewdell JW; Hutchinson E; Marazzi I
Cell; 2020 Jun; 181(7):1502-1517.e23. PubMed ID: 32559462
[TBL] [Abstract][Full Text] [Related]
46. Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II.
Engelhardt OG; Smith M; Fodor E
J Virol; 2005 May; 79(9):5812-8. PubMed ID: 15827195
[TBL] [Abstract][Full Text] [Related]
47. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
[TBL] [Abstract][Full Text] [Related]
48. RNA Editing with Viral RNA-Dependent RNA Polymerase.
Ogasawara S; Yamada A
ACS Synth Biol; 2022 Jan; 11(1):46-52. PubMed ID: 34978432
[TBL] [Abstract][Full Text] [Related]
49. Initiation, Elongation, and Realignment during Influenza Virus mRNA Synthesis.
Te Velthuis AJW; Oymans J
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142123
[TBL] [Abstract][Full Text] [Related]
50. Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells.
Vreede FT; Chan AY; Sharps J; Fodor E
Virology; 2010 Jan; 396(1):125-34. PubMed ID: 19875144
[TBL] [Abstract][Full Text] [Related]
51. Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?
Burgui I; Yángüez E; Sonenberg N; Nieto A
J Virol; 2007 Nov; 81(22):12427-38. PubMed ID: 17855553
[TBL] [Abstract][Full Text] [Related]
52. Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms.
Boivin S; Cusack S; Ruigrok RW; Hart DJ
J Biol Chem; 2010 Sep; 285(37):28411-7. PubMed ID: 20538599
[TBL] [Abstract][Full Text] [Related]
53. Host Determinants of Influenza RNA Synthesis.
Peacock TP; Sheppard CM; Staller E; Barclay WS
Annu Rev Virol; 2019 Sep; 6(1):215-233. PubMed ID: 31283439
[TBL] [Abstract][Full Text] [Related]
54. [Gene expression of influenza viruses during replication].
Hongo S; Muraki Y
Nihon Rinsho; 2006 Oct; 64(10):1795-802. PubMed ID: 17037351
[TBL] [Abstract][Full Text] [Related]
55. Towards an atomic resolution understanding of the influenza virus replication machinery.
Ruigrok RW; Crépin T; Hart DJ; Cusack S
Curr Opin Struct Biol; 2010 Feb; 20(1):104-13. PubMed ID: 20061134
[TBL] [Abstract][Full Text] [Related]
56. Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA.
De Vlugt C; Sikora D; Rocheleau L; Pelchat M
Virology; 2019 Oct; 536():91-100. PubMed ID: 31404845
[TBL] [Abstract][Full Text] [Related]
57. An efficient screening system for influenza virus cap-dependent endonuclease inhibitors.
Shibagaki Y; Ikuta N; Iguchi S; Takaki K; Watanabe S; Kaihotsu M; Masuda C; Maeyama K; Mizumoto K; Hattori S
J Virol Methods; 2014 Jun; 202():8-14. PubMed ID: 24613941
[TBL] [Abstract][Full Text] [Related]
58. The cap-binding site of influenza virus protein PB2 as a drug target.
Severin C; Rocha de Moura T; Liu Y; Li K; Zheng X; Luo M
Acta Crystallogr D Struct Biol; 2016 Feb; 72(Pt 2):245-53. PubMed ID: 26894672
[TBL] [Abstract][Full Text] [Related]
59. Deep sequencing reveals the eight facets of the influenza A/HongKong/1/1968 (H3N2) virus cap-snatching process.
Sikora D; Rocheleau L; Brown EG; Pelchat M
Sci Rep; 2014 Aug; 4():6181. PubMed ID: 25154590
[TBL] [Abstract][Full Text] [Related]
60. The cap-snatching reaction of yeast L-A double-stranded RNA virus is reversible and the catalytic sites on both Gag and the Gag domain of Gag-Pol are active.
Fujimura T; Esteban R
Mol Microbiol; 2019 Feb; 111(2):395-404. PubMed ID: 30427078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
